Starbucks: sell signal at week one, confirmation closes against the trend
Starbucks receives a sell signal in its first week, but the confirmation week closed higher: the model suggests exiting the position. Trading not recommended, stock 11.5% above the 200-week average, ranked 111th among 114 US sell signals.
Sanofi: decline continues but loses momentum, double bottom on the daily chart
Sanofi is in the 5th week of a sell signal, down -4.77%. The technical picture is mixed: the MACD histogram has reduced bearish pressure, but CMF has turned negative again and momentum continues to deteriorate. Our model flags elevated-risk conditions.
Safran: buy signal at week 2, weak confirmation
Safran is at week 2 of a buy signal on Euronext. The confirmation week closed bearish: the model flags an exit. The dynamic stop sits tight at -6% from entry; continuing the trade is at the trader's discretion.
Recursion Pharmaceuticals: the decline stalls, confirmation week closes bullish
Recursion Pharmaceuticals is in its 3rd week of a sell signal. The confirmation week closed bullish and the model suggests exiting the position: weakened signal, trading not recommended.
RTX Corporation: decline holds, but the sell-side is losing momentum
RTX Corporation is in week 11 of a sell signal. The decline is still active, but technical indicators point to a gradual fading of bearish pressure: rising buy volume, CMF back in positive territory, daily double bottom in the 171 area.
Roku: buy running, 3 targets hit, roadmap entering the final stretch
Roku is in the 9th week of a buy trade running +40%. All 3 statistical targets have already been hit, but the management roadmap runs through week 10: the stop is at breakeven and downside risk is gone.